CD8A and neoplasm: At last, JC-001 drove the generation of CD8+ T cells in LLC1 tumor and the secretion of IL-12 p70 and IFN-γ to sensitize LLC1 tumor to chemotherapeutic drug cisplatin (CDDP) (46).